phosphorylcholine has been researched along with Birth Weight in 9 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
" We conclude that after giving two doses of Exosurf, further doses might best be delayed until after two days, and that further clinical evaluation of dosage regimens is required." | 2.67 | Turnover of exogenous artificial surfactant. ( Ashton, MR; Austin, NC; Hall, MA; Normand, IC; Postle, AD; Smith, DE, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (88.89) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Courtney, SE | 1 |
Long, W | 2 |
McMillan, D | 1 |
Walter, D | 2 |
Thompson, T | 1 |
Sauve, R | 1 |
Conway, B | 1 |
Bard, H | 2 |
Wach, R | 1 |
Darlow, B | 1 |
Bourchier, D | 1 |
Broadbent, R | 1 |
Knight, D | 1 |
Selby, R | 1 |
Cotton, RB | 1 |
Olsson, T | 1 |
Law, AB | 1 |
Parker, RA | 1 |
Lindstrom, DP | 1 |
Silberberg, AR | 1 |
Sundell, HW | 1 |
Sandberg, K | 1 |
Rossello, JD | 1 |
Hayward, PE | 1 |
Martell, M | 1 |
Del Barco, M | 1 |
Margotto, P | 1 |
Grandzoto, J | 1 |
Bastida, J | 1 |
Peña, J | 1 |
Villanueva, D | 1 |
Hamdan, AH | 1 |
Shaw, NJ | 1 |
Murdoch, E | 1 |
Kempley, ST | 1 |
Ashton, MR | 1 |
Postle, AD | 1 |
Hall, MA | 1 |
Austin, NC | 1 |
Smith, DE | 1 |
Normand, IC | 1 |
Corbet, A | 1 |
Cotton, R | 1 |
Courtney, S | 1 |
McGuiness, G | 1 |
Watts, J | 1 |
Smyth, J | 1 |
Chernick, V | 1 |
Phibbs, RH | 1 |
Ballard, RA | 1 |
Clements, JA | 1 |
Heilbron, DC | 1 |
Phibbs, CS | 1 |
Schlueter, MA | 1 |
Sniderman, SH | 1 |
Tooley, WH | 1 |
Wakeley, A | 1 |
9 trials available for phosphorylcholine and Birth Weight
Article | Year |
---|---|
Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Birth Weight; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female | 1995 |
Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Topics: Birth Weight; Cerebral Hemorrhage; Cohort Studies; Cost of Illness; Drug Combinations; Fatty Alcohol | 1994 |
The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Topics: Biological Products; Birth Weight; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Human | 1993 |
Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
Topics: Birth Weight; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant Mo | 1997 |
Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
Topics: Acceleration; Biological Products; Birth Weight; Blood Pressure; Cardiac Output; Drug Combinations; | 1998 |
The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
Topics: Biological Products; Birth Weight; Diuresis; Drug Combinations; Fatty Alcohols; Gestational Age; Hum | 2000 |
Turnover of exogenous artificial surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Birth Weight; Chromatography, High Pressure Liquid; Drug Combina | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-U | 1991 |
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow | 1991 |